(S)-2-(3-Amino-4-((S)-2-amino-3-(4-hydroxyphenyl)-propanamido)benzamido)-3-(1H-indol-3-yl)propanoic Acid

ID: ALA3416717

Chembl Id: CHEMBL3416717

PubChem CID: 118734284

Max Phase: Preclinical

Molecular Formula: C27H27N5O5

Molecular Weight: 501.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1cc(C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)ccc1NC(=O)[C@@H](N)Cc1ccc(O)cc1

Standard InChI:  InChI=1S/C27H27N5O5/c28-20-12-16(7-10-23(20)31-26(35)21(29)11-15-5-8-18(33)9-6-15)25(34)32-24(27(36)37)13-17-14-30-22-4-2-1-3-19(17)22/h1-10,12,14,21,24,30,33H,11,13,28-29H2,(H,31,35)(H,32,34)(H,36,37)/t21-,24-/m0/s1

Standard InChI Key:  FTZXABLXAQZRNN-URXFXBBRSA-N

Alternative Forms

  1. Parent:

    ALA3416717

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 501.54Molecular Weight (Monoisotopic): 501.2012AlogP: 2.39#Rotatable Bonds: 9
Polar Surface Area: 183.56Molecular Species: ACIDHBA: 6HBD: 7
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 9#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.82CX Basic pKa: 8.01CX LogP: -0.01CX LogD: -0.10
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: -0.22

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source